Valuation: DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 2.11TCr 312.01Cr 272.66Cr 251.6Cr 231.92Cr 437.12Cr 30TCr 446.82Cr 3.01TCr 1.18TCr 15TCr 1.17TCr 1.15TCr 51TCr P/E 2026 *
14.2x
P/E 2027 * 12.3x
Enterprise Value 1.76TCr 260.09Cr 227.29Cr 209.74Cr 193.33Cr 364.38Cr 25TCr 372.47Cr 2.51TCr 986.02Cr 12TCr 976.76Cr 955.33Cr 42TCr EV / Sales 2026 *
0.59x
EV / Sales 2027 * 0.52x
Free-Float
34.77%
Yield 2026 *
4.85%
Yield 2027 * 5.35%
1 day-3.53%
1 week+5.21%
Current month+23.55%
1 month+15.56%
3 months+6.79%
6 months-2.26%
Current year+5.39%
1 week 17.58
Extreme 17.58
19.96
1 month 14.39
Extreme 14.39
19.96
Current year 14.39
Extreme 14.39
21.78
1 year 14.39
Extreme 14.39
21.78
3 years 11.92
Extreme 11.92
30.22
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.0028
61.63
Manager TitleAgeSince
Chief Executive Officer 44 28/02/2019
Director of Finance/CFO 44 10/05/2018
Human Resources Officer 48 -
Director TitleAgeSince
Director/Board Member 63 08/08/2016
Chairman 59 16/07/2013
Chairman 48 28/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
-3.53%+5.21%+7.97%-31.30% 312.01Cr
-5.05%-0.21%-20.55%-32.27% 1.51TCr
-3.17%-3.17%-27.59%-35.26% 692.78Cr
+2.53%+4.48%-20.75%-1.77% 613.35Cr
-2.80%+3.58%-11.74%-31.41% 372.58Cr
+2.36%+1.93%-37.73%-10.94% 325.07Cr
-0.11%-1.03%-30.41%-49.47% 314.83Cr
+0.37%-1.07%+94.71% - 256.58Cr
+0.98%+3.41%-18.63%-1.07% 253.05Cr
-0.92%-1.23%+2.61%+35.01% 167.09Cr
Average -0.93%+0.86%-6.21%-17.61% 482.15Cr
Weighted average by Cap. -1.97%+0.57%-13.83%-23.96%

Financials

2026 *2027 *
Net sales 2.99TCr 441.21Cr 385.57Cr 355.79Cr 327.95Cr 618.13Cr 42TCr 631.85Cr 4.25TCr 1.67TCr 21TCr 1.66TCr 1.62TCr 72TCr 3.3TCr 487.33Cr 425.88Cr 392.99Cr 362.24Cr 682.75Cr 47TCr 697.91Cr 4.7TCr 1.85TCr 23TCr 1.83TCr 1.79TCr 79TCr
Net income 148.46Cr 22Cr 19Cr 18Cr 16Cr 31Cr 2.11TCr 31Cr 211.11Cr 83Cr 1.03TCr 82Cr 80Cr 3.56TCr 171.45Cr 25Cr 22Cr 20Cr 19Cr 35Cr 2.44TCr 36Cr 243.8Cr 96Cr 1.19TCr 95Cr 93Cr 4.11TCr
Net Debt -351.92Cr -52Cr -45Cr -42Cr -39Cr -73Cr -5TCr -74Cr -500.43Cr -196.83Cr -2.45TCr -194.98Cr -190.7Cr -8.43TCr -400.97Cr -59Cr -52Cr -48Cr -44Cr -83Cr -5.7TCr -85Cr -570.19Cr -224.27Cr -2.79TCr -222.16Cr -217.29Cr -9.6TCr
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
17/26/17 CN¥18.57 -3.53% 96,52,935
16/26/16 CN¥19.25 0.00% 1,08,80,532
15/26/15 CN¥19.25 -2.18% 1,79,79,224
14/26/14 CN¥19.68 +8.85% 1,97,82,719
13/26/13 CN¥18.08 +2.44% 89,20,661
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
18.57CNY
Average target price
24.70CNY
Spread / Average Target
+33.01%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603233 Stock